v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenue $ 6,530 $ 2,798
Cost of revenue 3,858 986
Gross profit 2,672 1,812
Operating expenses:    
Research and development 1,724 852
Selling, general and administrative 3,297 2,002
Total operating expenses 5,021 2,854
Loss from operations (2,349) (1,042)
Interest and other expense, net:    
Interest expense, net (930) (691)
Other expense, net (4) (8,749)
Change in fair value of warrant liability (173) (705)
Change in fair value of derivative liability 0 101
Change in fair value of earnout liability 50 (50)
Total interest and other expense, net (1,057) (10,094)
Net loss (3,406) (11,136)
Net loss attributable to common stockholders $ (3,406) $ (11,136)
Net loss per share, basic (in dollars per share) [1] $ (0.25) $ (1.21)
Net loss per share, diluted (in dollars per share) [1] $ (0.25) $ (1.21)
Weighted-average shares outstanding, basic (in shares) [1] 13,798 9,172
Weighted-average shares outstanding, diluted (in shares) [1] 13,798 9,172
[1] Share and per share amounts for the three months ended March 31, 2025 differ from those published in prior unaudited condensed consolidated financial statements as they were retrospectively adjusted as a result of the Reverse Stock Split (refer to Note 1 - The Company and Summary of Significant Accounting Policies). Specifically, the number of common shares outstanding during the periods before the Reverse Stock Split are divided by the exchange ratio of 3:1, such that each three shares of common stock were combined and reconstituted into one share of common stock effective October 23, 2025.